The Regulation of PCSK9 Structure and Function Through Lipoprotein Interactions
Proprotein convertase subtilisin / kexin type 9 (PCSK9) is a negative regulator of the low-density lipoprotein receptor, and PCSK9 inhibition has become an important cholesterol-lowering therapeutic strategy. PCSK9 also associates with LDL particles, and evidence suggests that the activity of PCSK9...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en |
| Published: |
Université d'Ottawa / University of Ottawa
2019
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10393/39099 http://dx.doi.org/10.20381/ruor-23347 |